Search results for "Bone density"

showing 10 items of 339 documents

Estrogen receptor alpha polymorphism modifies the association between childhood exercise and bone mass: follow-up study.

2007

This follow-up study confirms our previous findings that the ER-α PvuII polymorphism (Pp) modulates the association between exercise and bone mass. The differences in bone properties of girls with consistently low physical activity (LLPA) and consistently high physical activity (HHPA) were evident only in those bearing the heterozygote ER-α genotype (Pp). In particular, areal bone mineral density of the total femur, bone mineral content and areal bone mineral density of the femoral neck, and bone mineral content and cortical thickness of the tibia shaft were significantly (p < .05) lower in the Pp girls with LLPA than in their HHPA counterparts. These findings might partly explain the ge…

medicine.medical_specialtyHeterozygoteBone densityGenotypePhysical Therapy Sports Therapy and RehabilitationCohort StudiesAbsorptiometry PhotonBone DensityInternal medicineGenotypemedicineHumansOrthopedics and Sports MedicineFemurChildExerciseFemoral neckBone mineralBone DevelopmentPolymorphism Geneticbusiness.industryEstrogen Receptor alphaHeterozygote advantagemedicine.anatomical_structureEndocrinologyPediatrics Perinatology and Child HealthLinear ModelsFemalebusinessEstrogen receptor alphaBone massFollow-Up StudiesPediatric exercise science
researchProduct

The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.

2009

Polymorphisms of the CYP450 genes that encode for the enzymes that metabolize estrogen are linked to hormone-related cancers. We investigated the impact of two polymorphisms of the CYP1B1 gene previously reported to be associated with hormone-related disorders on estrogen metabolism and bone mineral density (BMD), another hormone-dependent condition, in women from different ethnic backgrounds. Four hundred sixty-eight postmenopausal Caucasian women, 220 from St. Louis, MO, USA (mean age=63.5+/-0.53 years) and 248 from Palermo, Italy (mean age=72.9+/-0.44 years) participated in the study. Measurements of urinary estrogen metabolites by enzyme-linked immunoassay, serum estradiol by ultrasensi…

medicine.medical_specialtyHistologyBone densityGenotypePhysiologymedicine.drug_classEndocrinology Diabetes and MetabolismOsteoporosisHypoestrogenismBiologyArticleBone DensityLeucineRisk FactorsInternal medicineGenotypemedicineHumansGenetic Predisposition to DiseaseAlleleFemoral neckPolymorphism GeneticEstrogensValineMiddle Agedmedicine.diseaseMenopausemedicine.anatomical_structureEndocrinologyEstrogenCytochrome P-450 CYP1B1FemaleAryl Hydrocarbon HydroxylasesBone
researchProduct

Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density.

2009

Polymorphisms of the sex hormone-binding globulin (SHBG) gene are associated with differences in SHBG levels, influencing the risk for breast cancer and polycystic ovarian syndrome, but no association has been reported for osteoporosis in postmenopausal women.To determine the effect of G to A substitution in the 5'UTR (rs1799941) and the Asp356Asn (rs6259) polymorphisms of the SHBG gene on bone mineral density (BMD).This is a cross-sectional study in a university-based research center from May, 2002 to December, 2007. A total of two hundred and thirteen healthy postmenopausal Caucasian womenor = 1 year from last menstrual period participated to this study. Serum estradiol by ultrasensitive …

medicine.medical_specialtyHistologyBone densityGlobulinGenotypePhysiologyEndocrinology Diabetes and MetabolismOsteoporosisBiologyPolymorphism Single NucleotideArticleBreast cancerSex hormone-binding globulinBone DensityInternal medicineSex Hormone-Binding GlobulinGenotypemedicineHumansBone mineralImmunoradiometric assayEstradiolMiddle Agedmedicine.diseaseEndocrinologybiology.proteinFemale5' Untranslated RegionsBone
researchProduct

Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women.

2002

The purpose of this intervention trial was to determine whether changes in bone mass distribution could be observed in postmenopausal women following hormone replacement therapy (HRT) and/or high-impact physical exercise. Eighty healthy women, aged 50-57 years, at5 years after the onset of menopause and with no previous use of HRT, were randomly assigned to one of four groups: HRT; exercise (Ex); HRT + Ex (ExHRT); and control (Co). HRT administration was conducted in a double-blind manner for 1 year using estradiol plus noretisterone acetate (Kliogest). The exercise groups participated in a 1 year progressive training program consisting of jumping and bounding activities. Subjects participa…

medicine.medical_specialtyHistologyBone diseaseBone densityPhysiologyEndocrinology Diabetes and MetabolismOsteoporosisUrologyPhysical exerciseDouble-Blind MethodBone DensitymedicineHumansTibiaQuantitative computed tomographyExerciseBone mineralAnalysis of Variancemedicine.diagnostic_testEstradiolbusiness.industryEstrogen Replacement TherapyMiddle Agedmedicine.diseaseSurgeryPostmenopauseNorethindrone Acetatemedicine.anatomical_structureCortical boneFemalesense organsNorethindronebusinessBone
researchProduct

Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial.

2003

In this randomized, double-blind, placebo-controlled 12-month trial we evaluated effects of weight- bearing jumping exercise and oral alendronate, alone or in combination, on the mass and structure of bone, risk factors for falling (muscle strength and power, postural sway, and dynamic balance), and cardiorespiratory fitness in postmenopausal women. A total of 164 healthy, sedentary, early postmenopausal women were randomly assigned to one of four experimental groups: (1) 5 mg of alendronate daily plus progressive jumping exercise, (2) 5 mg alendronate, (3) placebo plus progressive jumping exercise, or (4) placebo. The primary endpoint was 12-month change in bone mass and geometry (measured…

medicine.medical_specialtyHistologyBone diseasePhysiologyEndocrinology Diabetes and MetabolismOsteoporosisUrologyPhysical exerciseBone remodelingDouble-Blind MethodBone DensityRisk FactorsmedicineConfidence IntervalsHumansExercise physiologyExerciseFemoral neckLumbar VertebraeAlendronatebusiness.industryFemur NeckAlendronic acidMiddle Agedmedicine.diseaseSurgeryPostmenopausemedicine.anatomical_structureCortical boneFemaleBone Remodelingbusinessmedicine.drugBone
researchProduct

The population-based prevalence of osteoporotic vertebral fracture and densitometric osteoporosis in postmenopausal women over 50 in Valencia, Spain …

2010

Purpose: To estimate the prevalence of vertebral fracture and densitometric osteoporosis in postmenopausal women over the age of 50 in Valencia, Spain. Methods: This cross-sectional study was conducted in 2006-2007. An age-stratified population-based random sample of 824 postmenopausal women over the age of 50 answered a questionnaire and received a densitometric examination of the lumbar spine and hip with dual-energy X-ray absorptiometry and a lateral X-ray of the thoracic spine and lumbar regions. Osteoporosis was defined as a T-score less than or equal to -2.5 compared to a population of young women, and the presence of vertebral fractures was classified according to Genant's semiquanti…

medicine.medical_specialtyHistologyPhysiologyEndocrinology Diabetes and MetabolismOsteoporosisPopulationPrevalenceLumbarAbsorptiometry PhotonBone DensityInternal medicineSurveys and QuestionnairesEpidemiologyMedicineHumansFemureducationOsteoporosis PostmenopausalFemoral neckAgedAged 80 and overeducation.field_of_studybusiness.industryMiddle Agedmedicine.diseaseVertebraSurgerymedicine.anatomical_structureCross-Sectional StudiesSpainSpinal FracturesFemalebusinessOsteoporotic FracturesBone
researchProduct

Weight-bearing, muscle loading and bone mineral accrual in pubertal girls--a 2-year longitudinal study.

2007

Abstract Objectives: The mechanical environment is considered to be the most important determinant of bone strength. Local muscle force, in turn, is regarded as the largest source of loading applied to bones. However, the effect of weight-bearing on bone mineral accrual is unclear. Comparing the relationship between muscle force and bone mineral content (BMC) in the upper and lower limbs provides a means of investigating this issue. Subjects and methods : The study group comprised 258 healthy girls aged 10–13 years old at baseline. BMC, lean body mass (LM) and fat body mass (FM) of total body were assessed by dual-energy X-ray absorptiometry at baseline and 2 years after. The maximal isomet…

medicine.medical_specialtyHistologyTime FactorsAdolescentPhysiologyEndocrinology Diabetes and MetabolismCoefficient of variationElbowIsometric exercisemedicine.disease_causeWeight-bearingBody Mass IndexWeight-BearingBone DensitymedicineHumansLongitudinal StudiesChildBone mineralOrthodonticsbusiness.industryMusclesPubertymusculoskeletal systembody regionsmedicine.anatomical_structureLean body massPhysical therapyUpper limbFemalemedicine.symptombusinesshuman activitiesMuscle contractionFollow-Up StudiesMuscle ContractionBone
researchProduct

Complex regional pain syndrome: An optimistic perspective.

2014

Complex regional pain syndrome (CRPS) presents with clinical symptoms that can no longer be explained by the initial trauma, including pain, sensory, motor, and trophic symptoms, and impairment of autonomic control of the limb. These symptoms spread distally and go beyond single nerve innervation territories. Typically, the symptoms change through the course of CRPS as a result of the varying pathophysiology. Diagnosis is made clinically after the rigorous elimination of other possible causes, and 3-phase bone scintigraphy can be a useful tool for confirming CRPS. In acute stages, inflammatory symptoms prevail and should be treated with anti-inflammatory agents (steroids), bisphosphonates, …

medicine.medical_specialtyImagery PsychotherapyImplosive TherapyPainMotor imageryOccupational TherapyNeuroplasticitymedicineHumansKetamineGlucocorticoidsPhysical Therapy ModalitiesAnalgesicsmedicine.diagnostic_testBone Density Conservation AgentsDiphosphonatesbusiness.industrySensory lossmedicine.diseaseComorbidityComplex regional pain syndromeBone scintigraphyAutonomic Nervous System DiseasesHyperalgesiaHyperalgesiaPhysical therapyKetamineNeurology (clinical)medicine.symptombusinessComplex Regional Pain Syndromesmedicine.drugNeurology
researchProduct

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw.

2013

Intravenous bisphosphonates (BP) play a key role in the treatment of bone metastases. As a long-term side effects BP, a form of avascular osteonecrosis of the jaw has been reported. Although, invasive oral local procedures are often present in clinical history of patients suffering from bisphosphonates-related osteonecrosis of the jaws (BRONJ), about up to 50% of BRONJ are spontaneous. We report a case of a 68-year-old female with a spontaneous wide bone sequestration of the left mandibular body onset after infusion of zoledronic acid for 18 cycles for osseous metastasis due to metastatic anaplastic thyroidal carcinoma. Surprisingly the clinical aspects of the patient initially reminded us …

medicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentBone NeoplasmsZoledronic AcidBone sequestrationstomatognathic systemMandibular bodySettore MED/28 - Malattie OdontostomatologichemedicineCarcinomaHumansMandibular DiseasesThyroid Neoplasmsthyroidal carcinomaGeneral DentistryAgedPhossy jawBone Density Conservation AgentsDiphosphonatesbusiness.industryCarcinomaMandibleImidazolesBisphosphonatesGeneral MedicineBisphosphonatemedicine.diseaseBisphosphonatesbisphosphonates‑related osteonecrosis of the jaws thyroidal carcinoma zoledronic acidbisphosphonates-related osteonecrosis of the jawsSurgerylcsh:RK1-715stomatognathic diseasesZoledronic acidlcsh:DentistryBisphosphonate-Associated Osteonecrosis of the JawFemaleOsteonecrosis of the jawbusinessmedicine.drugFollow-Up Studies
researchProduct

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents

2015

Background The clinical management of medication-related osteonecrosis of the jaw (MRONJ) in patients treated with bisphosphonates and other antiresorptive agents is subject to controversy. The American Association of Oral and Maxillofacial Surgeons (AAOMS) has developed guidelines for the correct management of the disorder which are revised and updated by a panel of experts. Material and Methods The present systematic review analyzes the different treatments currently used to treat this clinical condition, based on the PRISMA® (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement published in 2009. An electronic Medline search was made of the PubMed database, cover…

medicine.medical_specialtyMEDLINEAlternative medicineDentistryDiseaseReview03 medical and health sciences0302 clinical medicineAntiresorptive AgentsmedicineHumansStage (cooking)Intensive care medicineGeneral DentistryBisphosphonate-associated osteonecrosis of the jawBone Density Conservation AgentsDiphosphonatesbusiness.industryOsteonecrosis030206 dentistrymedicine.diseaseMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]Systematic reviewOtorhinolaryngology030220 oncology & carcinogenesisTooth ExtractionUNESCO::CIENCIAS MÉDICASSurgeryBisphosphonate-Associated Osteonecrosis of the JawbusinessOsteonecrosis of the jaw
researchProduct